2010 Webcasts
“mTOR inhibitors”
Fabrice André, MD, PhD, Institut Gustave Roussy, FRANCE
“PARP Ιnhibitors”
Nicholas Turner, Senior Lecturer and Honorary Consultant in Medical Oncology, Royal Marsden Hospital and Institute of Cancer Research, UK
"The Multidisciplinary Nature of Cancer Care"
J. Gordon McVie, MD, FRCP, FRCS Ed, FMedSci, DSc(Hon), Senior Consultant, Scientific Directorate, IEO Istituto Europeo di Oncologia, ITALY
"Applying Research Lessons to the Treatment of Advanced Colon Cancer"
John L. Marshall, MD, Professor, Chief Hematology Oncology, Georgetown University, USA
"Intra-operative radiotherapy for breast cancer; An Innovative Approach for the 21st Century"
Jeffrey Tobias, Professor of Cancer Medicine and Consultant in Clinical Oncology, University College London, UK
“Intraperitoneal chemotherapy for ovarian cancer (PRO)”
Deborah Armstrong, Associate Professor of Oncology, Gynecology and Obstetrics, Johns Hopkins Kimmel Cancer Center, USA
“Intraperitoneal Chemotherapy for Ovarian Cancer (CONTRA)”
Eric Pujade-Lauraine, Head of Medical Oncology, Department Hopital Hotel-Dieu, FRANCE
"Anthracyclines Should Remain a Component of Adjuvant Chemotherapy in Breast Cancer"
Norman Wolmark, Chairman, NSABP (National Surgical Adjuvant Breast and Bowel Project), USA
“Identification of a New Treatable Subset: The Colon Cancer Profile”
Gauri Varadhachary, Associate Professor of Medicine, UT MD Anderson Cancer Center, USA
“Treatment Directed by Molecular Profiling Results: Preliminary Report of a Prospective Study”
John D. Hainsworth, Chief Scientific Officer, Sarah Cannon Research Institute, USA
